Metformine Zentiva

Metformin, the active ingredient in Metformine Zentiva, is a biguanide presented as a tablet for oral use. It is used to improve glycemic control in patients with type 2 diabetes mellitus. GNH USA supplies Metformine Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformine Zentiva, a biguanide, is employed in the management of disorders of glucose metabolism. - Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. - Gestational diabetes: helps achieve target glucose control during pregnancy. - Prediabetes (impaired glucose tolerance): delays progression to overt diabetes.

Metformine Zentiva may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools, especially early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: decreased absorption with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: life‑threatening metabolic acidosis, especially in renal impairment. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Hypoglycemia: when combined with other glucose‑lowering agents. - Anemia: rare hemolytic events. - Pancreatitis: inflammation of the pancreas.

Before initiating Metformine Zentiva, certain safety considerations are recommended. - Renal function assessment: avoid use in severe renal impairment. - Hepatic function monitoring: contraindicated in active liver disease. - Risk of lactic acidosis: evaluate for conditions predisposing to hypoxia. - Elderly patients: start at lower dose and monitor tolerance. - Alcohol consumption: limit intake to reduce acidosis risk. - Store at room temperature: keep in the original packaging, protect from moisture.

Metformine Zentiva can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate renal dysfunction and lactic acidosis. - Cimetidine: can increase metformin plasma concentrations. - Carbonic anhydrase inhibitors (e.g., acetazolamide): raise risk of acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics (loop or thiazide): can affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and electrolytes.